64Cu-PD-32766

N/A

Report date: 2025/11/20 16:00:37
NME

Base Information

Drug Name64Cu-PD-32766
Drug Alias Name64Cu-PD-32766
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionCarbonic anhydrase IX inhibitors
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsColorectal Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsColorectal Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A